EUVIMEDEUVIMED entdecken
Crossref

Development of a broad-spectrum multiepitope vaccine against dabie bandavirus through immunoinformatic approaches

Muhammad Naveed, Muhammad Asim, Tariq Aziz, Maryam Manzoor Saqi, Hafiz Muzzammel Rehman, Wafa Abdullah I Al-Megrin, Ashwag Shami, Maher S Alwethaynani, Deema Fallatah, Fakhria A Al-Joufi, Ayaz Ali Khan

International Immunopharmacology · 2025-12 · 166 · 115492

DOI: 10.1016/j.intimp.2025.115492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-12. Verfasst von Muhammad Naveed und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore 54000, Pakistan. Electronic address: naveed.quai…. Hauptthemen laut MEDLINE: Epitopes, T-Lymphocyte, Viral Vaccines, Viral Envelope Proteins. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Princess Nourah Bint Abdulrahman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dabie bandavirus is an emerging tick-borne disease-causing high morbidity and mortality in East Asia, with no vaccines or targeted antiviral therapies. In this study, a multiepitope vaccine was designed using an immunoinformatic strategy to provide robust immune protection. The envelope polyprotein sequence was obtained from UniProt, and epitope prediction, conservancy screening, structural modeling, docking, immune simulations, codon optimization, and other computational analyses were performed. High antigenic, non-allergenic, and non-toxic T-cell epitopes were selected. The vaccine construct comprised 215 amino acids, exhibited an antigenicity score of 0.6922 and was predicted to be non-allergenic and non-toxic. Population coverage of selected T cell epitopes was found to be 89.76 % globally. The vaccine was calculated to be stable, soluble with a solubility score of 0.799, and thermally resistant. The predicted tertiary structure of the vaccine by Alphafold3 after refinement showed 97.7 % residues in the most favored region of the ramachandran plot. The molecular docking results of the vaccine with TLR4 showed the lowest energy of -1401.8 kcal/mol with the presence of 11 hydrogen bonds. Molecular dynamics simulations showed stable interactions between the vaccine and TLR4 receptor with an average RMSD of 4.5 Å and Rg of 30.0 Å. Free energy and PCA analysis confirmed thermodynamic stability and flexible yet stable interactions, supporting its immunogenic potential. Immune simulation analysis suggested durable responses from both B and T epitopes with increased cytokine production with IFN-γ and IL-2. In silico cloning into the pET28a(+) plasmid after codon optimization showed the possibility of expressing the vaccine, with GC content improving from 67.13 % to 54.42 %. However, further experimental validation is needed to check the safety and immune activation ability of the designed vaccine against Dabie bandavirus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epitopes, T-LymphocyteViral VaccinesViral Envelope ProteinsMolecular Docking SimulationAnimalsMolecular Dynamics SimulationVaccine DevelopmentHumansComputational BiologyToll-Like Receptor 4

Stichwörter der Autor:innen

B-cell epitopesDabie bandavirusImmune simulationsMolecular docking molecular dynamic simulationsMultiepitope vaccineT-cell epitopes

Substanzen

Epitopes, T-LymphocyteViral VaccinesToll-Like Receptor 4Viral Envelope Proteins

Autor:innen und Institutionen

  • Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore 54000, Pakistan. Electronic address: naveed.quaidian@gmail.com.
  • Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore 54000, Pakistan.
  • Laboratory of Animal Health, Hygiene and Food Quality University of Ioannina Arta, Greece.
  • School of Biochemistry & Biotechnology, University of the Punjab, Lahore, Pakistan.
  • Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh 11671, Saudi Arabia.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Alquwayiyah, Riyadh, Saudi Arabia.

Förderung

  • Princess Nourah Bint Abdulrahman University

Zitieren

APA

Naveed, M., Asim, M., Aziz, T., Saqi, M. M., Rehman, H. M., Al-Megrin, W. A. I., Shami, A., Alwethaynani, M. S., Fallatah, D., Al-Joufi, F. A., & Khan, A. A. (2025). Development of a broad-spectrum multiepitope vaccine against dabie bandavirus through immunoinformatic approaches. International Immunopharmacology, 166, 115492. https://doi.org/10.1016/j.intimp.2025.115492

Vancouver

Naveed M, Asim M, Aziz T, Saqi MM, Rehman HM, Al-Megrin WAI, et al. Development of a broad-spectrum multiepitope vaccine against dabie bandavirus through immunoinformatic approaches. International Immunopharmacology. 2025;166:115492. doi:10.1016/j.intimp.2025.115492

BibTeX
@article{Naveed2025,
  author = {Naveed, Muhammad and Asim, Muhammad and Aziz, Tariq and Saqi, Maryam Manzoor and Rehman, Hafiz Muzzammel and Al-Megrin, Wafa Abdullah I and Shami, Ashwag and Alwethaynani, Maher S and Fallatah, Deema and Al-Joufi, Fakhria A and Khan, Ayaz Ali},
  title = {Development of a broad-spectrum multiepitope vaccine against dabie bandavirus through immunoinformatic approaches},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {166},
  pages = {115492},
  doi = {10.1016/j.intimp.2025.115492}
}
Kostenlos starten →